Loading live market data…

Xenon Pharmaceuticals Inc.

NASDAQ:XENE

$67.3 USD

-$0.42 (-0.62%)

Volume
1.05M
Average Volume
1.41M
Market Capitalization
$5.31B
P/E Ratio
-14.32
Dividend Yield
0.00%
Price Target
$89.50
Year High
$72.66
Year Low
$30.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$27.79

XENE Estimated and Actual Revenue by Quarter

XENE Estimated and Actual EPS by Quarter

XENE Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 15 -567.98K -567.98K -567.98K -567.98K -567.98K -567.98K
2027-09-30 8 -1.5M -1.5M -1.5M -1.5M -1.5M -1.5M
2027-06-30 8 -9999 -9999 -9999 -9999 -9999 -9999
2027-03-31 0 - - - - - -
2026-12-31 15 -280.31K -280.31K -280.31K -280.31K -280.31K -280.31K
2026-09-30 8 -266.67K -266.67K -266.67K -266.67K -266.67K -266.67K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 15 -125.41M -125.41M -125.41M 9.82M 9.82M 9.82M
2027-09-30 8 -115.79M -115.79M -115.79M 25.93M 25.93M 25.93M
2027-06-30 8 -115.98M -115.98M -115.98M 172.87K 172.87K 172.87K
2027-03-31 0 -112.88M -112.88M -112.88M - - -
2026-12-31 15 -106.67M -106.67M -106.67M 4.85M 4.85M 4.85M
2026-09-30 8 -116.34M -89.02M -103.12M 4.61M 4.61M 4.61M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 15 2.84M 2.84M 2.84M 4 -1.4358 -1.4358 -1.4358
2027-09-30 8 7.5M 7.5M 7.5M 4 -1.3256 -1.3256 -1.3256
2027-06-30 8 50000 50000 50000 4 -1.32778 -1.32778 -1.32778
2027-03-31 0 - - - 4 -1.29238 -1.29238 -1.29238
2026-12-31 15 1.4M 1.4M 1.4M 4 -1.22124 -1.22124 -1.22124
2026-09-30 8 1.33M 1.33M 1.33M 10 -1.33195 -1.01914 -1.18059